Moreover, this study only investigated the incidence of CI-AKI in patients with acute myocardial infarction; the effect of PCSK9 inhibitors on CI-AKI incidence in other ASCVD (Atherosclerotic Cardiovascular Disease) patients undergoing PCI remains to be prospectively studied. Here, PCSK9 is linked to acute myocardial infarction.